Coya Therapeutics, Inc. (COYA)
5.01
+0.12
(+2.45%)
USD |
NASDAQ |
Sep 21, 16:00
5.01
0.00 (0.00%)
After-Hours: 20:00
Coya Therapeutics Total Liabilities (Quarterly) : 4.032M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.032M |
| March 31, 2026 | 4.301M |
| December 31, 2025 | 6.922M |
| September 30, 2025 | 4.758M |
| June 30, 2025 | 5.142M |
| March 31, 2025 | 5.035M |
| December 31, 2024 | 4.770M |
| September 30, 2024 | 3.542M |
| June 30, 2024 | 4.682M |
| March 31, 2024 | 5.000M |
| Date | Value |
|---|---|
| December 31, 2023 | 5.627M |
| September 30, 2023 | 1.807M |
| June 30, 2023 | 1.221M |
| March 31, 2023 | 1.266M |
| December 31, 2022 | 16.79M |
| September 30, 2022 | 14.42M |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 1.148M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.873M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 47.31M |
| Shareholders Equity (Quarterly) | 43.28M |
| Current Ratio | 13.40 |